Advanced search
Publication Cover
Platelets Volume 33, 2022 - Issue 6
Submit an article Journal homepage
296
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant

Hong Tian1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Danqing Kong1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Yun Li1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Chengyuan Gu1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Ziqiang Yu1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Zhaoyue Wang1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
,
Depei Wu1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaView further author information
&
Jie Yin1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;2 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China;3 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 951-953 | Received 05 Oct 2021, Accepted 22 Nov 2021, Published online: 16 Dec 2021

References

  • Niparuck P, Atichartakarn V, Chuncharunee S. Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin. Int J Hematol 2008;88:223–226. doi:10.1007/s12185-008-0125-0.
  • Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, Masaki Y, Hirose Y, Kuwana M, Umehara H. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus 2008;17:210–214. doi:10.1177/0961203307086032.
  • Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired amegakaryocytic thrombocytopenia in adult-onset still’s disease: successful combination therapy with tocilizumab and cyclosporine. Intern Med 2019;58:3473–3478. doi:10.2169/internalmedicine.2929-19.
  • Dragani M, Andreani G, Familiari U, Marci V, Rege-Cambrin G. Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: the uncharted territory. Clin Case Rep 2020;8:598–601.
  • Kishore J. Real time PCR reconfirmed three novel clinical associations of parvovirus B19: non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis. Indian J Med Res 2015;142:88–89. doi:10.4103/0971-5916.162132.
  • Levy I, Laor R, Jiries N, Bejar J, Polliack A, Tadmor T. Amegakaryocytic thrombocytopenia and subsequent aplastic anemia associated with apparent epstein-barr virus infection. Acta Haematol 2018;139:7–11. doi:10.1159/000484595.
  • Iyama S, Takada K, Yoshida M, Takahashi D, Kobune M. Acquired amegakaryocytic thrombocytopenic purpura possibly induced by anti-PD-1 antibody. Ann Hematol 2020;99:1669–1670. doi:10.1007/s00277-020-04053-y.
  • Novotný JP, Köhler B, Max R, Egerer G. Acquired amegakaryocytic thrombocytopenic purpura progressing into aplastic anemia. Prague Med Rep 2017;118:147–155. doi:10.14712/23362936.2017.16.
  • Erkurt MA, Kaya E, Baran M, Yitmen E, Şenel S, Kuku İ, Aydoğdu İ. Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic syndrome: case report. Turk J Haematol 2005;22:205–208.
  • Gupta L, Gupta V, Pani KC, Mittal N, Agarwal V. Successful use of azathioprine in glucocorticoid refractory immune amegakaryocytic thrombocytopenia of lupus. Reumatol Clin 2020;16:249–250. doi:10.1016/j.reuma.2018.03.005.
  • Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther 2019;12:115–118. doi:10.1016/j.hemonc.2017.09.001.
  • Ku H, Yonemura Y, Kaushansky K, Ogawa M. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996;87:4544–4551. doi:10.1182/blood.V87.11.4544.bloodjournal87114544.
  • Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 2017;376:1540–1550. doi:10.1056/NEJMoa1613878.
  • Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N, Yazdanbakhsh K. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 2010;116:4639–4645.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.